Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19
Currently, there is a persisting dispute regarding the renin-angiotensin-aldosterone-system (RAAS) inhibitors' safety of use in COVID-19 pandemics. On one side, RAAS inhibitors appear to determine an overexpression of ACE2, the receptor of SARS-CoV-2. Therefore, they could increase the risk of...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Journal of Ideas in Health
2021-07-01
|
| Series: | Journal of Ideas in Health |
| Subjects: | |
| Online Access: | https://jidhealth.com/index.php/jidhealth/article/view/125 |